Figure 1.
Disposition of MM-003 trial participants as of September 1, 2013. AE: adverse event; HiDEX: high-dose dexamethasone; LoDEX: low-dose dexamethasone; PD: progressive disease; POM: pomalidomide; Tx: treatment.
Disposition of MM-003 trial participants as of September 1, 2013. AE: adverse event; HiDEX: high-dose dexamethasone; LoDEX: low-dose dexamethasone; PD: progressive disease; POM: pomalidomide; Tx: treatment.